Hypothyroidism in MDR-TB treatment – Rare occurrence but a major concern
Context: To achieve good cure rate during treatment of MDR-TB, strict adherence to treatment regimen is a must. As the second line drugs have great potential to cause adverse drug reactions (ADR), identifying these adverse reactions and treating them early is major factor in preventing default. Hypo...
Main Authors: | J.S. Akshata, R. Swapna, Anushree Chakraborty, M. Somashekar, Shashidhar Buggi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-07-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763815201070 |
Similar Items
-
Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful
by: J.S. Akshata, et al.
Published: (2016-04-01) -
Prolonged use of bedaquiline in the treatment for MDR-TB in a child
by: Marina F. Gubkina, et al.
Published: (2021-01-01) -
Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01) -
‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01) -
MDR TB Transmission, Singapore
by: Cynthia B.E. Chee, et al.
Published: (2013-07-01)